Fahr’s Syndrome: A Multidisciplinary Analysis of Clinical and Radiological Findings

Can Imaging Speak? A Comprehensive Case Study on BG-Thalamic Calcifications

🔍 Patient Information: 

Age/Sex: 70-year-old male

Complaint: Dizziness, balance disturbance

History:

Similar calcifications were noted on a brain CT performed 6 years ago.

Imaging:

New brain CT and MRI show

bilateral basal ganglia and thalamic calcifications.

Laboratory:

 Blood glucose: 123 mg/dL (borderline diabetic, but not acutely significant)

 Calcium and phosphorus: Normal

 PTH and magnesium: Not tested

Bilateral globus pallidus and thalamic calcifications

Thin linear hyperdensity in the right parieto-occipital cortex (CT)

🧠 Interpretation of CT and MRI Findings:

📍 1. Bilateral globus pallidus and thalamic calcifications:

Appearance: Symmetric, bilateral, and present for at least 6 years.

MRI findings:

 Mild hyperintensity on T1-weighted sequences

 Not clearly visible on T2 and other sequences

→ Consistent with calcification

  🧩 Comment:

Although the distribution still suggests metabolic, toxic, or genetic etiologies,

this is not a newly developed process but a long-standing, stable condition.

This raises the possibility of congenital, metabolic, or genetic causes as higher priority.

📍 2. Thin linear hyperdensity in the right parieto-occipital cortex (CT):

Low attenuation, calcification-like but not definitive

No clear correlate on MRI, DWI is negative

 Contrast-enhanced MRI was not performed

Partial differential diagnosis:

Subacute cortical infarct/residue

Cortical venous thrombosis sequela

Linear dystrophic calcification

Post-ischemic gliotic change

Hemosiderin deposition (microhemorrhage sequela)

⚖️ Interim Evaluation:

🧠 Nature of the calcifications:

Symmetric, bilateral, stable for at least 6 years

Located in globus pallidus and thalamus

 This pattern is more consistent with primary (congenital/genetic) brain calcification syndromes.

Fahr disease (idiopathic bilateral striopallidodentate calcification) is particularly notable.

---

❗ Missing Data:

PTH not tested:

→ If normal, hypoparathyroidism is excluded

→ If low, it would be diagnostic

Magnesium not tested:

→ Hypomagnesemia may cause secondary hypoparathyroidism

No contrast-enhanced MRI:

→ Cortical lesion cannot be fully characterized

MRV result not reported:

→ Cortical venous thrombosis cannot be excluded

🧭 Conclusion and Recommendations :

1. The symmetric, stable, and long-standing nature of the calcifications makes primary calcification syndromes (especially Fahr disease) more likely.

2. Fahr disease:

Typically involves globus pallidus, thalamus, dentate nucleus

Broad clinical spectrum (e.g., epilepsy, parkinsonism, dementia, psychiatric symptoms)

Family history should be assessed; genetic testing (SLC20A2, PDGFRB, XPR1) may be warranted

3. Metabolic causes should still be considered, as some secondary forms may remain silent for years

→ PTH and magnesium should be tested

4. The clinical significance of the linear cortical hyperdensity is unclear

→ Contrast-enhanced MRI is needed

→ Could reflect vascular/ischemic/glial changes or hemosiderin deposition

5. Further clinical correlation needed:

Are extrapyramidal signs present?

Vestibular testing should be performed

EEG if necessary (e.g., if encephalopathy or seizures suspected)

🔬 Recommended Follow-Up :

  Test                                           Purpose

PTH                                             Evaluate for primary/secondary hypoparathyroidism

Magnesium                                 Assess for hypomagnesemia-related PTH suppression

Contrast-enhanced MRI             Characterization of cortical lesion

MRV                                             Rule out cortical venous thrombosis

Genetic testing                            (SLC20A2, PDGFRB)

 If Fahr disease

is suspected  

For a more in-depth radiological analysis, including differential diagnosis of secondary Fahr-like calcifications and clinical correlations.

Read Full Case Study